Dr. Benjamin Barnes, MD
Osteopathic Manipulative Medicine (Neuromusculoskeletal Medicine & OMM Physician)
- Medicare participating
At a glance
- Medical school
- University of Kentucky College of Medicine (2015)
- Years since graduation
- 11
- In the NPI registry since
- 2015
- Medicare patients seen, 2024
- 205
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2015Medical school: University of Kentucky College of Medicine
- 2015Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neuromusculoskeletal Medicine & OMM Physician primary
GA license 82840 -
Neurology Physician
KY license R3705 -
Neuromuscular Medicine (Psychiatry & Neurology) Physician
GA license 82840
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Map: Osteopathic Manipulative Medicine per capita by county →
Where they work
Hospitals
- Wellstar Mcg Health, Affiliated With Med Col Augusta, GA
- Piedmont Augusta Hospital Augusta, GA
- Aiken Regional Medical Center Aiken, SC
Medical groups
- Wellstar Medical Group LLC (3,093 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 205
- Services billed
- 511
- Patients’ average age
- 69
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 20-29 minutes | 91 | 71 |
| Established patient office or other outpatient visit, 40-54 minutes | 83 | 65 |
| Needle measurement of electrical activity in arm or leg muscles, limited study | 59 | 37 |
| Established patient office or other outpatient visit, 30-39 minutes | 57 | 50 |
| New patient office or other outpatient visit, 60-74 minutes | 41 | 41 |
| Needle measurement of electrical activity in arm or leg muscles, complete study | 35 | 29 |
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 33 | 19 |
| Nerve conduction, 3-4 studies | 29 | 28 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | 29 | 16 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 26 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Radicava Ors (edaravone) | 136 |
| Riluzole | 41 |
| Gabapentin Other prescribers in Augusta, GA | 37 |
| Baclofen Other prescribers in Augusta, GA | 36 |
| Glycopyrrolate Other prescribers in Augusta, GA | 29 |
| Pyridostigmine Bromide Other prescribers in Augusta, GA | 28 |
| Mycophenolate Mofetil Other prescribers in Augusta, GA | 28 |
| Prednisone Other prescribers in Augusta, GA | 20 |
| Vyvgart (efgartigimod alfa-fcab) | 18 |
| Diazepam Other prescribers in Augusta, GA | 17 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 19 companies reported 81 payments worth $2,121 in total to this clinician.
| UCB, Inc. | $327 |
|---|---|
| Argenx US, Inc. | $247 |
| Alexion Pharmaceuticals, Inc. | $245 |
| Takeda Pharmaceuticals U.S.A., Inc. | $221 |
| Csl Behring | $160 |
| Biogen, Inc. | $158 |
| AbbVie Inc. | $157 |
| Tanabe Pharma America, Inc. | $138 |
| Food and Beverage | $2,098 |
|---|---|
| Education | $23.42 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Csl Behring May 12, 2025 | Education Hizentra · Immunology · in-kind | $11.71 |
| Csl Behring Jul 14, 2025 | Education Hizentra · Immunology · in-kind | $11.71 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $40,548 in research payments for these studies, mostly to the institutions running them.
- Study to Assess the Effects of PTC857 Treatment in Participants With Amyotrophic Lateral Sclerosis ALS
Ptc Therapeutics, Inc. · Terminated · NCT05349721 - A randomized, double-blind, placebo-controlled phase III study to evaluate the efficacy, safety, and tolerability of iptacopan in patients with generalized Myasthenia Gravis (gMG), followed by an open label extension …
Novartis Pharmaceuticals Corporation
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.